Cat: IPD-X24488

Recombinant Haemophilus influenzae Outer membrane 蛋白 A/OmpA Protein,His & SUMO

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    Outer membrane 蛋白 A/OmpA

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    Fimbrin

  • 种属

    Haemophilus influenzae

  • 表达系统

    E. coli

  • 标签

    N- His-SUMO & C- Myc

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    P45996

  • 表达区间

    22-359aa

  • 分子量

    56.4 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Outer membrane protein A (OmpA) is a crucial component of the outer membrane of Gram-negative bacteria, playing significant roles in maintaining membrane integrity, facilitating nutrient transport, and contributing to bacterial pathogenesis. Due to its abundant expression and immunogenicity, OmpA has garnered attention as a potential target for vaccine development and therapeutic intervention. Research into OmpA has revealed its ability to form oligomers, its involvement in biofilm formation, and its role in host-pathogen interactions. Furthermore, the recombinant production of OmpA has become a focal point for functional studies, allowing for the exploration of its structural and biochemical properties without the complexities associated with the native bacterial context. This research not only aids in understanding the mechanistic details of OmpA's function but also enhances the development of OmpA-based applications, including diagnostics and drug delivery systems. The ongoing studies of OmpA emphasize its potential as a versatile platform for biotechnological applications, prompting further investigation into its recombinant forms and the implications for infectious disease management.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US